Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
Giornale Italiano Di Cardiologia
|
June 1, 1991
[The irrelevance of the clinical arterial pressure with respect to outpatient pressure in defining the risk of left ventricular hypertrophy in essential arterial hypertension]
G Schillaci, P Verdecchia, F Boldrini, et al.
Journal of Hypertension
|
November 29, 2001
High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension
G Schillaci, G Vaudo, G Reboldi, et al.
Circulation
|
January 27, 1998
Prognostic significance of serial changes in left ventricular mass in essential hypertension
P Verdecchia, G Schillaci, C Borgioni, et al.
The American Journal of Cardiology
|
November 24, 1999
Value of a simple echocardiographic linear predictor of left ventricular mass in systemic hypertension
P Verdecchia, G Reboldi, G Schillaci, et al.
Journal of Hypertension
|
September 24, 1998
Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension
P Verdecchia, G Schillaci, C Borgioni, et al.
The American Journal of Cardiology
|
February 1, 1994
Asymmetric left ventricular remodeling due to isolated septal thickening in patients with systemic hypertension and normal left ventricular masses
P Verdecchia, C Porcellati, I Zampi, et al.
American Journal of Hypertension
|
February 1, 1995
Gender, day-night blood pressure changes, and left ventricular mass in essential hypertension. Dippers and peakers
P Verdecchia, G Schillaci, C Borgioni, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1993
Low mid-wall fractional shortening identifies a subgroup of hypertensive patients with increased left ventricular mass and ambulatory blood pressure
C Porcellati, P Verdecchia, G Schillaci, et al.
Journal of Hypertension
|
September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril
N J Holwerda, R Fogari, P Angeli, et al.
Journal of Hypertension
|
October 1, 1995
Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension
P Verdecchia, G Schillaci, C Borgioni, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
Giornale Italiano Di Cardiologia
|
June 1, 1991
[The irrelevance of the clinical arterial pressure with respect to outpatient pressure in defining the risk of left ventricular hypertrophy in essential arterial hypertension]
G Schillaci, P Verdecchia, F Boldrini, et al.
Journal of Hypertension
|
November 29, 2001
High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension
G Schillaci, G Vaudo, G Reboldi, et al.
Circulation
|
January 27, 1998
Prognostic significance of serial changes in left ventricular mass in essential hypertension
P Verdecchia, G Schillaci, C Borgioni, et al.
The American Journal of Cardiology
|
November 24, 1999
Value of a simple echocardiographic linear predictor of left ventricular mass in systemic hypertension
P Verdecchia, G Reboldi, G Schillaci, et al.
Journal of Hypertension
|
September 24, 1998
Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension
P Verdecchia, G Schillaci, C Borgioni, et al.
The American Journal of Cardiology
|
February 1, 1994
Asymmetric left ventricular remodeling due to isolated septal thickening in patients with systemic hypertension and normal left ventricular masses
P Verdecchia, C Porcellati, I Zampi, et al.
American Journal of Hypertension
|
February 1, 1995
Gender, day-night blood pressure changes, and left ventricular mass in essential hypertension. Dippers and peakers
P Verdecchia, G Schillaci, C Borgioni, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1993
Low mid-wall fractional shortening identifies a subgroup of hypertensive patients with increased left ventricular mass and ambulatory blood pressure
C Porcellati, P Verdecchia, G Schillaci, et al.
Journal of Hypertension
|
September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril
N J Holwerda, R Fogari, P Angeli, et al.
Journal of Hypertension
|
October 1, 1995
Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension
P Verdecchia, G Schillaci, C Borgioni, et al.
Page
of 9